Target Name: PLAC8
NCBI ID: G51316
Review Report on PLAC8 Target / Biomarker Content of Review Report on PLAC8 Target / Biomarker
PLAC8
Other Name(s): onzin | C15 | placenta associated 8 | Placenta-specific gene 8 protein | PNAS-144 | Placenta associated 8, transcript variant 1 | Onzin | DGIC | PLAC8_HUMAN | placenta specific 8 | down-regulated in gastrointestinal cancer protein | Protein C15 | PLAC8 variant 1

PLAC8: A Protein Involved in Cell Signaling and Apoptosis

PLAC8 (Onzin) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a member of the oncogene PIK3CA family, which encodes proteins that are involved in cell signaling pathways. PLAC8 is unique among the PIK3CA family members because it is able to interact with the protein p21, which is a negative regulator of the T-cell receptor signaling pathway. This interaction between PLAC8 and p21 has important implications for the regulation of cell proliferation and survival.

One of the functions of PLAC8 is to regulate the activity of the T-cell receptor, which is a protein that is involved in the development and activation of T-cells. T-cells are a type of white blood cell that play a critical role in the immune system, and they are able to recognize and respond to the presence of foreign substances in the body. The T-cell receptor is involved in the signaling pathway that regulates the activation and proliferation of T-cells, and PLAC8 is able to interact with it to regulate its activity.

PLAC8 is also involved in the regulation of cell apoptosis, which is the process by which cells die and are removed from the body. During apoptosis, PLAC8 is able to interact with the protein Bcl-2, which is a protein that is involved in the regulation of cell death. This interaction between PLAC8 and Bcl-2 allows PLAC8 to regulate the activity of Bcl-2 and influence the decision of cells to undergo apoptosis.

In addition to its role in regulating T-cell receptor signaling and apoptosis, PLAC8 is also involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues. PLAC8 is able to interact with the protein Focal Adhesion Protein (FAP), which is involved in the regulation of cell adhesion. This interaction between PLAC8 and FAP allows PLAC8 to regulate the activity of FAP and influence the formation of tissues.

PLAC8 is also involved in the regulation of cell migration. Migration is the process by which cells move from one location to another in the body. PLAC8 is able to interact with the protein vimentin, which is involved in the regulation of cell migration. This interaction between PLAC8 and vimentin allows PLAC8 to regulate the activity of vimentin and influence the migration of cells.

In conclusion, PLAC8 is a protein that is involved in the regulation of various cellular processes in the body. Its unique ability to interact with the protein p21 and the T-cell receptor has important implications for the regulation of cell proliferation and survival. Furthermore, PLAC8's involvement in the regulation of cell adhesion and migration adds to its role in the regulation of cellular processes. PLAC8 is a potential drug target and may be a biomarker for various diseases.

Protein Name: Placenta Associated 8

The "PLAC8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLAC8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PLAC8L1 | PLAC9 | PLAC9P1 | PLAG1 | PLAGL1 | PLAGL2 | Plasma Membrane Calcium ATPase | PLAT | Platelet Glycoprotein Ib Complex | Platelet-activating factor acetylhydrolase isoform 1B complex | Platelet-Derived Growth Factor (PDGF) | Platelet-Derived Growth Factor Receptor | PLAU | PLAUR | PLB1 | PLBD1 | PLBD1-AS1 | PLBD2 | PLCB1 | PLCB2 | PLCB3 | PLCB4 | PLCD1 | PLCD3 | PLCD4 | PLCE1 | PLCE1-AS2 | PLCG1 | PLCG1-AS1 | PLCG2 | PLCH1 | PLCH2 | PLCL1 | PLCL2 | PLCXD1 | PLCXD2 | PLCXD3 | PLCZ1 | PLD1 | PLD2 | PLD3 | PLD4 | PLD5 | PLD6 | PLEC | PLEK | PLEK2 | PLEKHA1 | PLEKHA2 | PLEKHA3 | PLEKHA4 | PLEKHA5 | PLEKHA6 | PLEKHA7 | PLEKHA8 | PLEKHA8P1 | PLEKHB1 | PLEKHB2 | PLEKHD1 | PLEKHF1 | PLEKHF2 | PLEKHG1 | PLEKHG2 | PLEKHG3 | PLEKHG4 | PLEKHG4B | PLEKHG5 | PLEKHG6 | PLEKHG7 | PLEKHH1 | PLEKHH2 | PLEKHH3 | PLEKHJ1 | PLEKHM1 | PLEKHM1P1 | PLEKHM2 | PLEKHM3 | PLEKHN1 | PLEKHO1 | PLEKHO2 | PLEKHS1 | PLET1 | Plexin | PLG | PLGLA | PLGLB1 | PLGLB2 | PLGRKT | PLIN1 | PLIN2 | PLIN3 | PLIN4 | PLIN5 | PLK1 | PLK2 | PLK3 | PLK4 | PLK5 | PLLP | PLN